<p><b>A</b> Proportion of HIV drug resistance was determined using the first Prot/RT sequences from treatment naïve patients (n = 1950) by year according to the SDRM mutation list (Bennett et al. 2009). The proportion of TDR over time was stable at 10.4% (95% CI 9.1–11.8; p <i><sub>for trend</sub></i> = 0.6; 2001–2011). <b>B</b> Proportion of overall ADR (64%; 1,310/2,049 sequences; 95% CI 62–66) declined significantly over time (OR 0.8; 95% CI 0.77–0.83; p for trend<0.001; 2001–2011) in sequences from treated patients (n = 2,049) according to IAS mutation list 2011. <b>C</b> Proportion of ADR within different antiretroviral drug classes declined for all classes (NNRTI 55%, NRTI 51%, PI 30%; p for trend<0.001; 2001–2011) in sequences from p...
<p>The coloured graphs show the proportion of patients on treatment each year that had at least one ...
BACKGROUND Transmitted HIV-1 drug-resistance mutations(TDR) are transmitted from treatment-faili...
HIV-1 transmitted drug resistance (TDR) could reverse the gains of antiretroviral rollout. To ensure...
<p><b>A</b> Proportion of resistance mutations in first Prot/RT sequence from treatment naïve patien...
HIV drug resistance represents a major threat for effective treatment. We assessed the trends in the...
We assessed trends in the proportion of transmitted (TDR) and acquired (ADR) HIV drug resistance and...
BACKGROUND: HIV drug resistance represents a major threat for effective treatment. We assessed the t...
OBJECTIVES: To examine factors influencing the rate of transmitted drug resistance (TDR) among seroc...
Objectives: To examine factors influencing the rate of transmitted drug resistance (TDR) among seroc...
The prevalence of transmitted drug resistance (TDR) in antiretroviral therapy (ART)-naïve individual...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
Background: HIV drug resistance represents a major threat for effective treatment. We assessed the t...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
mL. Methods: The protease and reverse transcriptase (RT) genes were systematically sequenced in samp...
<p>(<b>A</b>) Trends of prevalence of TDR (percentage) and the 95% confidence intervals (light shadi...
<p>The coloured graphs show the proportion of patients on treatment each year that had at least one ...
BACKGROUND Transmitted HIV-1 drug-resistance mutations(TDR) are transmitted from treatment-faili...
HIV-1 transmitted drug resistance (TDR) could reverse the gains of antiretroviral rollout. To ensure...
<p><b>A</b> Proportion of resistance mutations in first Prot/RT sequence from treatment naïve patien...
HIV drug resistance represents a major threat for effective treatment. We assessed the trends in the...
We assessed trends in the proportion of transmitted (TDR) and acquired (ADR) HIV drug resistance and...
BACKGROUND: HIV drug resistance represents a major threat for effective treatment. We assessed the t...
OBJECTIVES: To examine factors influencing the rate of transmitted drug resistance (TDR) among seroc...
Objectives: To examine factors influencing the rate of transmitted drug resistance (TDR) among seroc...
The prevalence of transmitted drug resistance (TDR) in antiretroviral therapy (ART)-naïve individual...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
Background: HIV drug resistance represents a major threat for effective treatment. We assessed the t...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
mL. Methods: The protease and reverse transcriptase (RT) genes were systematically sequenced in samp...
<p>(<b>A</b>) Trends of prevalence of TDR (percentage) and the 95% confidence intervals (light shadi...
<p>The coloured graphs show the proportion of patients on treatment each year that had at least one ...
BACKGROUND Transmitted HIV-1 drug-resistance mutations(TDR) are transmitted from treatment-faili...
HIV-1 transmitted drug resistance (TDR) could reverse the gains of antiretroviral rollout. To ensure...